Skip to main content
J2KBIO Co., Ltd. logo

J2KBIO Co., Ltd. — Investor Relations & Filings

Ticker · 420570 ISIN · KR7420570004 KO Manufacturing
Open in API
Filings indexed 53 across all filing types
Latest filing 2024-09-05 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 420570

About J2KBIO Co., Ltd.

https://www.j2kbio.com/eng/

J2KBIO Co., Ltd. is a research and development-focused bio-venture company that designs and develops active ingredients and sustainable raw materials. The company utilizes natural ingredients and microorganisms, employing advanced processes such as microbial fermentation and its proprietary METABIOME technology. Its research focuses on exploring the interactions between its ingredients and the skin to discover materials with optimal efficacy. The resulting bio-materials are supplied for use in a variety of sectors, including cosmetics, personal care products, functional foods, and household goods. The company is committed to developing safe and beneficial ingredients for skin application while promoting a sustainable coexistence between people and nature.

Recent filings

Filing Released Lang Actions
전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds issued by J2K Bio. It details the number of shares to be issued, the conversion price, and the impact on total shares outstanding. This type of corporate action, involving the conversion of debt into equity, falls under capital structure changes and share issuance announcements, which is best classified as 'Share Issue/Capital Change' (SHA).
2024-09-05 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 제이투케이바이오' (J2KBIO Co., Ltd.) covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial information, business operations, and management discussions, which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-22 Korean
주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission and Korea Exchange regarding the decision to acquire tangible assets (land and buildings). This type of regulatory filing in the Korean market, which details specific corporate transactions like asset acquisitions, falls under the 'Regulatory Filings' category as it is a mandatory disclosure of a material event that does not fit into more specific categories like M&A or share issuance.
2024-07-31 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for J2KBIO Co., Ltd., covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial information, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider holdings and transactions by directors and major shareholders. In the provided taxonomy, 'Director's Dealing' (DIRS) is the correct category for reports concerning personal share transactions or ownership status by company directors and executives.
2024-03-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. This is a standard regulatory filing in South Korea used to disclose insider shareholdings and changes in ownership by directors or major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS) as it reports personal share ownership and changes by a company executive (Kim Seok-jong).
2024-03-29 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.